Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs

Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs

Integrase strand transfer inhibitors (INSTIs) are currently recommended for the first line treatment of human immunodeficiency virus type one (HIV-1) infection. The first-generation INSTIs are effective but can select for resistant viruses. Recent advances have led to several potent second-generatio...

Full description

Bibliographic Details
Main Authors:	Steven J. Smith, Xue Zhi Zhao, Dario Oliveira Passos, Dmitry Lyumkis, Terrence R. Burke, Stephen H. Hughes
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Viruses
Subjects:	HIV integration INSTIs drug resistance antiviral therapy
Online Access:	https://www.mdpi.com/1999-4915/13/2/205

Similar Items

HIV drug resistance against strand transfer integrase inhibitors
by: Kaitlin Anstett, et al.
Published: (2017-06-01)

Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco
by: Najwa Alaoui, et al.
Published: (2018-06-01)

Inhibition of HTLV-1 Infection by HIV-1 First- and Second-Generation Integrase Strand Transfer Inhibitors
by: Michał S. Barski, et al.
Published: (2019-08-01)

HIV-1 resistance patterns to integrase inhibitors in Chilean patients with virological failure on raltegravir-containing regimens
by: Pablo Ferrer, et al.
Published: (2020-09-01)

Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs
by: Alina Kirichenko, et al.
Published: (2020-07-01)

Discovery of Novel Integrase Inhibitors Acting outside the Active Site Through High-Throughput Screening
by: Cindy Aknin, et al.
Published: (2019-10-01)

Generation of soluble, catalytically active covalent HIV-1 subtype C integrase-DNA complexes to identify novel strand transfer inhibitors
by: Beyleveld, Grant James
Published: (2014)

Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa
by: Adetayo Emmanuel Obasa, et al.
Published: (2020-03-01)

The study of susceptibility and resistance of HIV integrases to integrase strand transfer inhibitors and the development of novel single domain antibody targeting HIV integrase
by: Ni, Xiaoju
Published: (2011)

Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence
by: Thibault Mesplède, et al.
Published: (2015-07-01)

Integrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo Acids
by: Vasu Nair, et al.
Published: (2015-07-01)

Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
by: Steven J. Smith, et al.
Published: (2018-05-01)

The study of susceptibility and resistance of HIV integrases to integrase strand transfer inhibitors and the development of novel single domain antibody targeting HIV integrase
by: Ni, Xiaoju
Published: (2011)

Quantum-Chemistry Based Design of Halobenzene Derivatives With Augmented Affinities for the HIV-1 Viral G4/C16 Base-Pair
by: Perla El Darazi, et al.
Published: (2020-06-01)

Genetic diversity and baseline drug resistance of South African HIV-1 Integrase sequences prior to the availability of Integrase strand-transfer inhibitors
by: Brado, Dominik Alexander
Published: (2020)

HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
by: Pratibha C Koneru, et al.
Published: (2019-05-01)

EFFICACY AND TOXICITY STUDIES OF LINKUS AND INSTY ANTIPYRETIC POLYHERBAL MEDICINES
by: Saira Bano, et al.
Published: (2016-06-01)

Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase
by: Kamal Singh, et al.
Published: (2019-04-01)

Molecular docking study of lamellarin analogues and identification of potential inhibitors of HIV-1 integrase strand transfer complex by virtual screening
by: Chatchakorn Eurtivong, et al.
Published: (2019-11-01)

Short Communication: Integrase Strand Transfer Inhibitors Drug Resistance Mutations in Puerto Rico HIV-Positive Individuals
by: Pablo López, et al.
Published: (2021-03-01)

Multiple choices for HIV therapy with integrase strand transfer inhibitors
by: Raffi Francois, et al.
Published: (2012-12-01)

Evidence for Disruption of Mg2+ Pair as a Resistance Mechanism Against HIV-1 Integrase Strand Transfer Inhibitors
by: Lucas de Almeida Machado, et al.
Published: (2020-08-01)

Historiografía sobre las significaciones imaginarias de infancia en la cultura de Occidente
by: Cecilia Rincón Verdugo
Published: (2018-01-01)

The study of susceptibility and resistance of HIV integrases to integrase strand transfer inhibitors and the development of novel single domain antibody targeting HIV integrase
by: Ni, Xiaoju
Published: (2011)

Improving outpatient primary medication adherence with physician guided, automated dispensing
by: Moroshek JG
Published: (2017-01-01)

Brief Overview of Vote Advisors (Proxy Advisors) in Peru
by: Edison Paul Tabra Ochoa
Published: (2017-12-01)

Resistance Analyses of Integrase Strand Transfer Inhibitors within Phase 3 Clinical Trials of Treatment-Naive Patients
by: Kirsten L. White, et al.
Published: (2014-07-01)

Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors
by: Isabelle Malet, et al.
Published: (2017-09-01)

Pharmacokinetic drug interactions of integrase strand transfer inhibitors
by: Chi-Hua Lu, et al.
Published: (2021-01-01)

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana
by: Kaelo K. Seatla, et al.
Published: (2021-03-01)

Evaluation of the NIH clinical collection to identify potential HIV-1 integrase inhibitors
by: Abrahams, Shaakira
Published: (2014)

Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
by: Aleksey Viktorovich Kravchenko, et al.
Published: (2010-11-01)

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
by: Karolin Meixenberger, et al.
Published: (2017-11-01)

In Silico and In Vitro Comparison of HIV-1 Subtypes B and CRF02_AG Integrases Susceptibility to Integrase Strand Transfer Inhibitors
by: Xiaoju Ni, et al.
Published: (2012-01-01)

Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors
by: Rossana Scutari, et al.
Published: (2020-03-01)

Design, synthesis and biological activity of novel HIV integrase inhibitors
by: Traut, Telisha
Published: (2012)

Development of an HIV-1 integrase enzyme strand transfer assay
by: Qasim, Muhammad
Published: (2011)

Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy
by: Alexander O Pasternak, et al.
Published: (2021-08-01)

HIV INTEGRASE INHIBITORS: THE BASIS OF EFFECTIVE AND SAFE ANTIRETROVIRAL THERAPY
by: V. I. SHAKHGILDYAN
Published: (2017-05-01)

Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome.
by: Michael E Abram, et al.
Published: (2017-01-01)